% | $
Quotes you view appear here for quick access.

Sequenom Inc. Message Board

  • viorel263 viorel263 Oct 24, 2013 4:16 PM Flag

    the real fight is Not patent '540, the real fight is US Patent Application No: 2013/0040,824

    US Patent Application No: 2013/0040,824


    Kind Code A1
    Lo; Yuk Ming Dennis ; et al.

    Filing date Nov 30, 2011

    Publication date Feb 14, 2013

    (serial)Control No 13/308,473

    Conflict of interest: Ownership: Sequenom. Other substantive relationships: Patent filing

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ________________

      App1.N0. 13/308,473
      Amdt. dated October 14, 2013 PATENT
      Response to Office Action of July 1, 2013

      Amendments to the Claims:

      This listing of claims will replace all prior versions, and listings of claims in the application:

      Listing of Claims:

      1 . (Canceled)

      2. (Currently Amended) The method of claim [[1]] A, wherein the first
      chromosomal region is classified as exhibiting a deletion or an amplification in cells associated
      with cancer, and wherein the cells associated with cancer include a malignant tumor and/or from
      a premalignant lesion.

      3. (Currently Amended) The method of claim [[1]] 5, wherein each locus of
      the first plurality of loci is at least 500 bases apart from another locus of the first plurality of loci.

      4 . (Currently Amended) :Phemethod—of—el-aim—l- A method of analyzing a
      biological sample of an organism for chromosomal deletions or amplifications associated with
      cancer, the biological sample including nucleic acid molecules originating from normal cells and
      potentiallv from cells associated with cancer, wherein at least some of the nucleic acid molecules
      are cell-free in the biological sample, the method comprising:

      determining first and second hanlotvnes for normal cells of the organism at a first
      chromosomal region, the first chromosomal region including a first nluralitv of loci, wherein the
      first and second hanlotvnes are heterozvgous at each of the first nluralitv of loci;

      for each of a nluralitv of the nucleic acid molecules in the biological sample:
      identifving a location of the nucleic acid molecule in a reference genome of
      the organism; and

      determining a respective allele of the nucleic acid molecule;

      identifving a first group of nucleic acid molecules as being from the first
      haplotvpe based on the identified locations and determined alleles, the first group including at
      least one nucleic acid molecule located at each of the first pluralitv of loci;

      Page 2 of 13

2.11+0.01(+0.48%)Oct 9 3:59 PMEDT